Comparison of cardiovascular risk prediction in type 1 diabetes: an Australian viewpoint

Savindi Wimalarathne1, Yuhan A Goh2, P Gerry Fegan2,3

  • 1Medical School, University of Western Australia, Perth, Western Australia, Australia.

Internal Medicine Journal
|December 14, 2024
PubMed

Insights

Determining cardiovascular disease (CVD) risk in type 1 diabetes mellitus (T1DM) is challenging. The Australian CVD risk calculator showed discrepancies compared to T1DM-validated tools, indicating a need for better risk assessment pathways in Australia.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) poses a significant health risk for individuals with type 1 diabetes mellitus (T1DM).
  • Accurate CVD risk stratification is crucial for effective prevention and management in this population.
  • Current risk assessment tools may not be optimally validated for T1DM.

Purpose of the Study:

  • To evaluate the performance of the new Australian CVD risk calculator in individuals with T1DM.
  • To compare the Australian calculator's risk categorization against established T1DM-specific risk engines.
  • To inform the development of appropriate CVD risk assessment strategies for T1DM patients in Australia.

Main Methods:

  • Comparative analysis of CVD risk predictions.
  • Utilizing the new Australian CVD risk calculator.
  • Benchmarking against the Steno Type 1 Risk Engine and a Swedish/Scottish prediction tool validated for T1DM.

Main Results:

  • The Australian CVD risk calculator demonstrated potential overestimation of risk compared to the Steno Type 1 Risk Engine.
  • The calculator showed potential underestimation of risk when compared to the Swedish/Scottish prediction tool.
  • Discrepancies highlight variability in risk categorization across different tools for T1DM.

Conclusions:

  • The optimal CVD risk stratification method for T1DM in Australia requires further investigation.
  • Existing general population risk calculators may not accurately reflect CVD risk in T1DM.
  • Development of a T1DM-specific CVD risk assessment pathway for Australia is warranted.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K